MET Form 4: Director Reinvests Dividends to Add 663 Shares at $79.29

Rhea-AI Filing Summary

Robert Glenn Hubbard, a director of MetLife, Inc. (MET), reported an acquisition on 09/09/2025 of 663 shares of MetLife common stock at a price of $79.29 per share. The filing shows the shares were credited through imputed reinvestment of dividends under the MetLife Deferred Compensation Plan for Non-Management Directors, meaning dividend payments that became payable were deferred and converted into additional deferred shares. After this transaction the reporting person beneficially owns 101,151 shares. The Form 4 was filed as a single reporting person filing and signed by an attorney-in-fact on 09/11/2025.

Positive

• Director ownership increased by 663 shares to a total of 101,151 shares following the reinvestment
• Transaction disclosed timely on Form 4 and executed through an established deferred compensation plan

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine director dividend reinvestment modestly increased insider ownership; not a material change.

The reported transaction is a common, non-discretionary imputed dividend reinvestment under MetLife’s deferred compensation arrangements for non-management directors. Such reinvestments convert payable shares into further deferred shares and do not reflect open-market purchases or sales. The incremental addition of 663 shares represents a small change relative to the reported post-transaction holding of 101,151 shares and is consistent with compensation plan mechanics rather than a deliberate trading decision by the director.

Securities Analyst

TL;DR: Acquisition via dividend reinvestment increases insider stake slightly; transaction type limits interpretive weight.

The Form 4 discloses an acquisition at $79.29 per share through imputed reinvestment of dividends, not a market purchase. While insider holdings rose to 101,151 shares, the absolute change of 663 shares is immaterial for valuation or control analysis. The disclosure is timely and complies with Section 16 reporting requirements; investors should note the mechanics but not infer an active trading signal from this filing alone.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HUBBARD ROBERT GLENN

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK NY 10166

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/09/2025		A(1)		663	A	$79.29	101,151	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Remarks:

	/s/ Taylor McInerney Jansen, Attorney-in-fact	09/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Robert Glenn Hubbard report on Form 4 for MET?

He reported an acquisition of 663 shares on 09/09/2025 at $79.29 per share via dividend reinvestment, resulting in 101,151 shares beneficially owned.

Was the transaction a market purchase or a dividend reinvestment?

The filing states it was an imputed reinvestment of dividends under the MetLife Deferred Compensation Plan for Non-Management Directors, not an open-market trade.

Does this Form 4 indicate a material change in insider ownership of MET?

No. The reported addition of 663 shares is small relative to the total holdings of 101,151 shares and reflects plan mechanics.

When was the Form 4 signed and filed?

The signature block shows the form was signed by an attorney-in-fact on 09/11/2025 and reports the transaction dated 09/09/2025.